t(8;9)(q24;p13) ?/MYC

2013-10-01   Jean-Loup Huret  

1.Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France

Clinics and Pathology

Disease

B-cell acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphoma (NHL)

Phenotype stem cell origin

There were 5 cases of ALL (L3-ALLs and CD10+ ALLs in 2 cases each), 11 cases of diffuse large B-cell lymphoma (DLBCL), 7 cases of unclassifiable B-cell lymphoma, one case of follicular lymphoma, and one case of diffuse mixed small and large cell lymphoma (Levine et al., 1989; Nacheva et al., 1993; Dunphy et al., 2003; DAchille et al., 2006; Bertrand et al., 2007; Le Gouill et al., 2007; Christie et al., 2008; Johnson et al., 2009; Subramaniyam et al., 2011).

Epidemiology

Twenty five cases are available. There were 12 male and 13 female patients, median age was 63 years (range 42-90 years). In a review of NHLs with a t(14;18)(q32;q21), the incidence of MYC translocations was 5%, and the incidence of t(8;9)(q24;p13) was 1% (Johansson et al., 1995).
Atlas Image
Meta-analysis of survival in patients with t(8;9)(q24;p13).

Prognosis

Median survival was 4 months (see figure). However, patients with an ALL died at 1, 1, 1.5, and 1.5 months. Median survival of patients with NHL was 6 months, and 3 out of 19 NHL patients were still alive 5 years after diagnosis (16%).

Genes Involved and Proteins

Note
Breakpoints occurred close to MYC on chromosome 8 and close to: ZBTB5, ZCCHC7, and PAX5 on chromosome 9 (Bertrand et al., 2007; Le Gouill et al., 2007; Johnson et al., 2009).
- ZBTB5 is a POZ domain Krüppel-like zinc finger transcription repressor. ZBTB5 interacted with co-repressor-histone deacetylase complexes such as BCOR, NCOR1, and NCOR2 (SMRT), resulting in deacetylation of histones Ac-H3 and Ac-H4, and transcriptional repression of CDKN1A (p21) (Koh et al., 2009).
- ZCCHC7 is the equivalent of the yeast AIR1. In yeast, a number of unwanted RNA transcripts are first recognized by the nuclear exosome cofactor Trf4/5p-Air1/2p-Mtr4p polyadenylation (TRAMP) complex before subsequent nuclear-exosome-mediated degradation. TRAMP facilitates pre-mRNA splicing (Kong et al., 2013).
- PAX5 is a lineage-specific transcription factor; recognizes the concensus recognition sequence GNCCANTGAAGCGTGAC, where N is any nucleotide. Involved in B-cell differentiation. Entry of common lymphoid progenitors into the B cell lineage depends on E2A, EBF1, and PAX5; activates B-cell specific genes and represses genes involved in other lineage commitments. Activates the surface cell receptor CD19 and represses FLT3. PAX5 physically interacts with the RAG1/RAG2 complex, and removes the inhibitory signal of the lysine-9-methylated histone H3, and induces V-to-DJ rearrangements. Genes repressed by PAX5 expression in early B cells are restored in their function in mature B cells and plasma cells, and PAX5 repressed (Fuxa et al., 2004; Johnson et al., 2004; Zhang et al., 2006; Cobaleda et al., 2007).
Gene name
MYC v-myc myelocytomatosis viral oncogene homolog (avian)
Location
8q24.21
Protein description
DNA binding protein. Binds DNA as a heterodimer with MAX. Involved in various cellular processes including cell growth, proliferation, cell adhesion, apoptosis, angiogenesis, and stem cell behaviour modulation.

Result of the Chromosomal Anomaly

Expression localisation

There was abundant MYC expression in all the cases studied.

Highly cited references

Pubmed IDYearTitleCitations
368356282023The "Superoncogene" Myc at the Crossroad between Metabolism and Gene Expression in Glioblastoma Multiforme.330
309094962019MYC Oncogene Contributions to Release of Cell Cycle Brakes.243
333222392020The Molecular 'Myc-anisms' Behind Myc-Driven Tumorigenesis and the Relevant Myc-Directed Therapeutics.230
224643212012MYC on the path to cancer.229
263821452015MYC, Metabolism, and Cancer.223
402901262025Targeting MYC: Multidimensional regulation and therapeutic strategies in oncology.193
285050712017MYC-Master Regulator of the Cancer Epigenome and Transcriptome.192
379419012023MYC function and regulation in physiological perspective.191
349424442022Therapeutic targeting of "undruggable" MYC.159
318325152019Writing and erasing MYC ubiquitination and SUMOylation.159
346588882021Targeting Myc Interacting Proteins as a Winding Path in Cancer Therapy.158
357414022022MTBP and MYC: A Dynamic Duo in Proliferation, Cancer, and Aging.156
282455972017MYC in Regulating Immunity: Metabolism and Beyond.142
252747552014Therapeutic strategies to inhibit MYC.138
364178492022MYC regulates a pan-cancer network of co-expressed oncogenic splicing factors.127
320714362020Target gene-independent functions of MYC oncoproteins.126
367346152023Demystifying the Druggability of the MYC Family of Oncogenes.122
336923312021Alternative approaches to target Myc for cancer treatment.121
341786662021Targeting the MYC Ubiquitination-Proteasome Degradation Pathway for Cancer Therapy.120
374571232023Targeting MYC-driven lymphoma: lessons learned and future directions.116
86157601996Myc oncogenes: the enigmatic family.112
321605432020MYC Dysregulates Mitosis, Revealing Cancer Vulnerabilities.105
330920252020MYC in Brain Development and Cancer.99
295273312018Targeting oncogenic Myc as a strategy for cancer treatment.97
385652492024A germline point mutation in the MYC-FBW7 phosphodegron initiates hematopoietic malignancies.84
212931882011Post-translational control of Myc function during differentiation.83
403116802025MYC controls STING levels to downregulate inflammatory signaling in breast cancer cells upon DNA damage.82
291730172020MYC leads the way.81
419702792026MYC and AP-1 oncogenes cooperatively bind enhancers to rewire transcription.80
246964542014Stress-induced cleavage of Myc promotes cancer cell survival.79
211134112010Myc, mondo, and metabolism.73
266978362015Deubiquitinating c-Myc: USP36 steps up in the nucleolus.71
290782882017PAF1 complex component Leo1 helps recruit Drosophila Myc to promoters.70
277568912016c-Myc deregulation induces mRNA capping enzyme dependency.69
327159942020Dissecting transcriptional amplification by MYC.68
316798232019Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy.67
363519452022Reversible Myc hypomorphism identifies a key Myc-dependency in early cancer evolution.66
403729722025Targeting processive transcription for Myc-driven circuitry in medulloblastoma.66
254757042015Taming of the beast: shaping Myc-dependent amplification.65
416988892026Palmitic acid activates c-Myc via dual palmitoylation-dependent pathways to promote colon cancer.64
256404022015Deregulated Myc requires MondoA/Mlx for metabolic reprogramming and tumorigenesis.64
243949402014c-MYC-miRNA circuitry: a central regulator of aggressive B-cell malignancies.63
245673692014The myc 3' wnt-responsive element suppresses colonic tumorigenesis.62
314551582019Oncogenic MYC amplifies mitotic perturbations.61
350897872022Two diphosphorylated degrons control c-Myc degradation by the Fbw7 tumor suppressor.60
310436112019Inhibition of MYC by the SMARCB1 tumor suppressor.56
288001272017Mnt modulates Myc-driven lymphomagenesis.55
275664022016MYC-nick promotes cell migration by inducing fascin expression and Cdc42 activation.55
205981172010Myc suppression of Nfkb2 accelerates lymphomagenesis.54
301585172018MYC dephosphorylation by the PP1/PNUTS phosphatase complex regulates chromatin binding and protein stability.54
350485592022A Selective Small-Molecule c-Myc Degrader Potently Regresses Lethal c-Myc Overexpressing Tumors.51
315705062019ZFP281 Recruits MYC to Active Promoters in Regulating Transcriptional Initiation and Elongation.51
324828682020MYC protein stability is negatively regulated by BRD4.50
352967952022Deubiquitination of MYC by OTUB1 contributes to HK2 mediated glycolysis and breast tumorigenesis.50
309116852019Myc-driven chromatin accessibility regulates Cdc45 assembly into CMG helicases.49
316381402020NSD3S stabilizes MYC through hindering its interaction with FBXW7.49
403650202025Rethinking MYC inhibition: a multi-dimensional approach to overcome cancer's master regulator.48
242978632014BET bromodomain inhibition of MYC-amplified medulloblastoma.46
342339622021The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma.43
233184342013Dual regulation of Myc by Abl.43
304534752018Targeting the MYC Oncogene in Burkitt Lymphoma through HSP90 Inhibition.41
316113672019Heterogeneity of Myc expression in breast cancer exposes pharmacological vulnerabilities revealed through executable mechanistic modeling.40
351676212022Cryptic MYC insertions in Burkitt lymphoma: New data and a review of the literature.39
267665872016The Interaction of Myc with Miz1 Defines Medulloblastoma Subgroup Identity.38
359621892022Myc inhibition tips the immune balance to promote antitumor immunity.36
360188502022S146L in MYC is a context-dependent activating substitution in cancer development.36
408868222025Targeting MKK3/c-Myc interaction to overcome osimertinib acquired resistance in EGFR mutant lung cancer.35
337913092021MYC Enhances Cholesterol Biosynthesis and Supports Cell Proliferation Through SQLE.34
354380572022Ubiquitylation of unphosphorylated c-myc by novel E3 ligase SCF(Fbxl8).32
368444672023AXL upregulates c‑Myc expression through AKT and ERK signaling pathways in breast cancers.30
319325762020High level MYC amplification in B-cell lymphomas: is it a marker of aggressive disease?28
381847532024Non-IG::MYC in diffuse large B-cell lymphoma confers variable genomic configurations and MYC transactivation potential.26
263831672015The MYC-WDR5 Nexus and Cancer.24
247042062015Myc and cell cycle control.0
335247942021MYC as a target for cancer treatment.0
340192882021MYC Analysis in Cancer and Evolution.0
240060542013The Myc world within reach.0
393066152024MYC upstream region orchestrates resistance to PI3K inhibitors in cancer cells through FOXO3a-mediated autophagic adaptation.0
30349331987Myc family of cellular oncogenes.0
375616332023A MYC-controlled redox switch protects B lymphoma cells from EGR1-dependent apoptosis.0
17515431991c-myc oncoprotein function.0
249331132015Myc and its interactors take shape.0
118855632002The myc oncogene: MarvelouslY Complex.0
255535142015MYC-mediated synthetic lethality for treating tumors.0
100782001999Ras enhances Myc protein stability.0
394682222025Transcriptional regulation by MYC: an emerging new model.0
310680322019MYC modulators in cancer: a patent review.0
340192902021Analysis of Myc Chromatin Binding by Calibrated ChIP-Seq Approach.0
255642542015MYC-mediated synthetic lethality for treatment of hematological malignancies.0
340192832021An "-omycs" Toolbox to Work with MYC.0
320745952020The Spectrum of MYC Alterations in Diffuse Large B-Cell Lymphoma.0
105799121999Function of the c-Myc oncogenic transcription factor.0
170128432006Myc overexpression enhances apoptosis induced by small molecules.0
103786941999The role of c-myc in cellular growth control.0
236963622013Myc in stem cell behaviour: insights from Drosophila.0
414894902026Alternative Strategies of Reducing MYC Expression for the Treatment of Cancers.0
303005802018MYC Interacts with the G9a Histone Methyltransferase to Drive Transcriptional Repression and Tumorigenesis.0
125658162003Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes.0
198060172009MYC, microRNAs and glutamine addiction in cancers.0
198879152009Myc's secret life without Max.0

Article Bibliography

Pubmed IDLast YearTitleAuthors
172302272007Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas.Bertrand P et al
182975232008C-MYC translocation in t(14;18) positive follicular lymphoma at presentation: An adverse prognostic indicator?Christie L et al
174404522007Pax5: the guardian of B cell identity and function.Cobaleda C et al
170745912006Translocation (14;18)(q32;q21) in acute lymphoblastic leukemia: a study of 12 cases and review of the literature.D'Achille P et al
127089082003Mature B-cell acute lymphoblastic leukemia with associated translocations (14;18)(q32;q21) and (8;9)(q24;p13). A Burkitt variant?Dunphy CH et al
150040082004Pax5 induces V-to-DJ rearrangements and locus contraction of the immunoglobulin heavy-chain gene.Fuxa M et al
75793601995Cytogenetic evolution patterns in non-Hodgkin's lymphoma.Johansson B et al
152585792004B cell-specific loss of histone 3 lysine 9 methylation in the V(H) locus depends on Pax5.Johnson K et al
195971842009Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival.Johnson NA et al
194913982009A novel POK family transcription factor, ZBTB5, represses transcription of p21CIP1 gene.Koh DI et al
240974362014Cotranscriptional recruitment of yeast TRAMP complex to intronic sequences promotes optimal pre-mRNA splicing.Kong KY et al
180243712007The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement.Le Gouill S et al
25069531989Four new recurring translocations in non-Hodgkin lymphoma.Levine EG et al
83242251993C-MYC translocations in de novo B-cell lineage acute leukemias with t(14;18)(cell lines Karpas 231 and 353).Nacheva E et al
217181392011De novo B lymphoblastic leukemia/lymphoma in an adult with t(14;18)(q32;q21) and c-MYC gene rearrangement involving 10p13.Subramaniyam S et al
166801442006Transcription factor Pax5 (BSAP) transactivates the RAG-mediated V(H)-to-DJ(H) rearrangement of immunoglobulin genes.Zhang Z et al

Citation

Jean-Loup Huret

t(8;9)(q24;p13) ?/MYC

Atlas Genet Cytogenet Oncol Haematol. 2013-10-01

Online version: http://atlasgeneticsoncology.org/haematological/2141/t(8